Early Detection Saves Lives

ColonAiQ® Revolutionary
Blood Test
for
Colorectal Cancer Screening

Colorectal cancer (CRC) is a critical health concern in Singapore and the Philippines. In Singapore, it’s the most common cancer overall and the second leading cause of cancer-related deaths.

Alarmingly, only about 40% of CRC cases are diagnosed at early stages, and just 38% of Singapore residents aged 50-74 undergo recommended CRC screening. Timely screening is crucial for early detection, which significantly improves treatment outcomes and survival rates. With early-stage CRC having over 90% 5-year survival rates compared to less than 10% for late-stage diagnoses, the importance of regular screening cannot be overstated.

ColonAiQ® offers a new, more accessible way to prioritize your health through early CRC detection.

Key Benefits Of ColonAiQ®

Higher Sensitivity

Higher Sensitivity: ColonAiQ® demonstrates superior sensitivity compared to FIT (Fecal Immunochemical Test): (5) (6)


  • Overall sensitivity: 88.3% vs. 59.7%
  • Stage I detection: 85.7% vs. 28.6%

Patient Preference

Patient Preference: Most patients prefer blood tests over stool-based tests, potentially increasing screening compliance. (4)


Earlier Detection

Improved Early Detection: ColonAiQ® significantly increases detection rates for precancerous adenomas and early-stage CRC compared to existing molecular screening tests. (6)


A Breakthrough in Early Detection

ColonAiQ® is a cutting-edge, multi-locus blood-based assay that targets circulating tumor DNA methylation. This innovative technology offers unparalleled success in non-invasive early detection of both colorectal cancer (CRC) and advanced adenoma (AA). (6)

Why Timely CRC Screening Matters?

Colorectal cancer is a critical health concern in Singapore and the Philippines:

Why Early Detection Matters?

Stage distribution of CRC in Singapore (2018-2021): (2)

Earlier detection leads to better treatment outcomes and improved survival rates.

Benefits of ColonAiQ®

01. https://gco.iarc.who.int/media/globocan/factsheets/populations/702-singapore-fact-sheet.pdf

02.https://www.nrdo.gov.sg/docs/librariesprovider3/default-document-library/scr-ar-2021-web-report.pdf?sfvrsn=591fc02c_0

03. https://hpb.gov.sg/docs/default-source/default-document-library/nphs-2022-survey-report.pdf?sfvrsn=3e8530aa_8

04. https://doi.org/10.1016/j.ctarc.2016.12.004
Liles, E. G., Coronado, G. D., Perrin, N., Harte, A. H., Nungesser, R., Quigley, N., Potter, N. T., Weiss, G., Koenig, T., & de Vos, T. (2017). Uptake of a colorectal cancer screening blood test is higher than of a fecal test offered in clinic: A randomized trial. Cancer Treatment and Research Communications, 10, 18-23. https://doi.org/10.1016/j.ctarc.2016.12.004

05. https://doi.org/10.1097/JS9.0000000000000260

Song, D., Wang, F., Ju, Y., He, Q., Sun, T., Deng, W., Ding, R., Zhang, C., Xu, Q., Qi, C., & Bao, J. (2023). Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review. International Journal of Surgery, 109(4), 925–935. https://doi.org/10.1097/JS9.0000000000000260

06. https://doi.org/10.1053/j.gastro.2021.08.054
Cai, G., Cai, M., Feng, Z., Liu, R., Liang, L., & Zhou, P. (2021). A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer. Gastroenterology, 161(6), 2053-2056.e2. https://doi.org/10.1053/j.gastro.2021.08.054

07. https://doi.org/10.1016/j.ctarc.2016.12.004

Liles, E. G., Coronado, G. D., Perrin, N., Harte, A. H., Nungesser, R., Quigley, N., Potter, N. T., Weiss, G., Koenig, T., & de Vos, T. (2017). Uptake of a colorectal cancer screening blood test is higher than of a fecal test offered in clinic: A randomized trial. Cancer Treatment and Research Communications, 10, 18-23. https://doi.org/10.1016/j.ctarc.2016.12.004

About Colonoscopy

https://www.gastrojournal.org/article/S0016-5085(21)03031-6/fulltext

Get In Touch

Kindly Note

ColonAiQ is undergoing Health Sciences Authority (HSA) review for registration in Singapore and the Philippines.

Sign up for our waitlist to be among the first to be notified when ColonAiQ becomes available! Please leave your contact details.